Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 46.25
Bid: 45.50
Ask: 47.00
Change: 1.75 (3.83%)
Spread: 1.50 (3.297%)
Open: 45.75
High: 47.50
Low: 47.50
Prev. Close: 45.75
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Blencowe And BlueRock Recommence Operations

Mon, 11th May 2020 12:03

(Alliance News) - The following is a round-up of updates by London-listed companies on the impact of the Covid-19 pandemic, issued on Monday and not separately reported by Alliance News:

----------

Open Orphan PLC - pharmaceutical services - Subsidiary hVIVO enters contract with Nasdaq-listed diagnostics firm Quotient to use MosaiQ system and MosaiQ Covid-19 antibody microarray to screen for SARS-CoV-2 antibodies, which is produced when humans are infected with Covid-19.

----------

Avacta Group PLC - biotherapeutics - To ship Affimer reagents for the development of a point-of-care saliva-based Covid-19 antigen test strip by Cytiva, for CE Marking in Europe and US Food & Drug Administration approval. Will also be sent to Adeptrix, which is developing Covid-19 laboratory test to run on hospital mass spectrometers.

----------

BlueRock Diamonds PLC - diamonds - Recommences operations at Kareevlei diamond mine in Kimberley, South Africa. Expects to start operations at full capacity by the end of May, but expansion plans on hold.

----------

Chesterfield Resources PLC - mineral exploration - Plans to resume drilling operations on its Troodos West licences by mid-June, following government of Cyprus providing a detailed four-phase roadmap out of lockdown, which is spread over the next two months up until July 14.

----------

Blencowe Resources PLC - mining - Recommences key metallurgical test work on Orom-Cross graphite project in Uganda, after being on hold for six weeks since late March due to lockdown. Due to restart 59-hole diamond drilling programme, which is designed to deliver a maiden JORC resource during the middle of 2020.

----------

Phoenix Spree Deutschland Ltd - real estate - Rent collection for April at 98% compared to 99% in January. Refinances EUR16.4 million in debt acquired as part of acquisition of Brandenburg apartment complex. Will pay second dividend of 5.15 cents per share, remain confident in long-term outlook.

----------

Petro Matad Ltd - Mongolian oil explorer - Executive directors, non-executive directors and senior managers to take salary cut averaging 50%, backdated to the start of second quarter of 2020. Professional advisers to reduce its fees by up to 45%. To focus on securing Block XX exploitation licence and retaining its Block V exploitation licence.

----------

Anglo African Agriculture PLC - agriculture investment - Trading subsidiary Dynamic Intertrade remains fully operational despite South Africa lockdown, due to providing essential services as a food manufacturer. Expects revenue for six months ending October 31 to double year-on-year. Progress with Comarco transaction protracted due to general market environment.

----------

iEnergizer Ltd - media and technology services - Continues to trade effectively in lockdown imposed by government of India. Business operating at 80% to 90% efficiency to its clients. Balance sheet, net cash position and long-term customer relationships remain strong.

----------

Cake Box Holdings PLC - cakes retailer - Following initial trial of limited number of stores operating Click & Collect service and delivery in partnership, now has 79 franchise stores open, offering a limited menu of products. Expects to have full high street estate open by early June.

----------

Midwich Group PLC - audio-visual distributor - Delivered strong performance in 2019, with growth in revenue and rise in profit. Challenging trading conditions over the past two months, expected to continue until lockdown conditions in Europe and North America are "significantly eased".

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
16 Feb 2021 11:31

AIM WINNERS & LOSERS: Cornish Metals Jumps 40% On AIM Debut

AIM WINNERS & LOSERS: Cornish Metals Jumps 40% On AIM Debut

Read more
16 Feb 2021 09:48

Avacta Shares Surge On Positive Data For Covid-19 Antigen Test

Avacta Shares Surge On Positive Data For Covid-19 Antigen Test

Read more
16 Feb 2021 09:38

Avacta upbeat on initial data for Covid-19 rapid test study

(Sharecast News) - Biotherapeutics and reagents developer Avacta Group has received the first data for its SARS-CoV-2 rapid antigen test from ongoing clinical studies in Europe and the UK, it announced on Tuesday.

Read more
8 Feb 2021 11:25

Avacta enters commercial partnership with Mologic

(Sharecast News) - Biotherapeutics developer Avacta Group has entered into a commercial partnership with Mologic, it announced on Monday, to accelerate to market its 'AffiDX' SARS-CoV-2 lateral flow rapid antigen test.

Read more
8 Feb 2021 10:46

AIM WINNERS & LOSERS: Bahamas Petroleum Sinks As Pulls Plug On Well

AIM WINNERS & LOSERS: Bahamas Petroleum Sinks As Pulls Plug On Well

Read more
8 Feb 2021 09:37

Avacta Signs Agreement With Mologic For AffiDX Covid-19 Antigen Test

Avacta Signs Agreement With Mologic For AffiDX Covid-19 Antigen Test

Read more
1 Feb 2021 14:37

TRADING UPDATES: Asiamet Hits Back At Shareholder; Hardide Raises Cash

TRADING UPDATES: Asiamet Hits Back At Shareholder; Hardide Raises Cash

Read more
1 Feb 2021 09:25

Avacta joint venture with Daewoong raises $7.3m in series A funding

(Sharecast News) - Biotherapeutics developer Avacta Group announced on Monday that its joint venture with Daewoong Pharmaceutical, AffyXell Therapeutics, has closed a series A venture capital investment of $7.3m (£5.32m) to further develop its pipeline of next generation cell and gene therapies.

Read more
28 Jan 2021 14:42

IN BRIEF: Avacta Lands Deal With Bruker To Assess SARS-CoV-2 Test

IN BRIEF: Avacta Lands Deal With Bruker To Assess SARS-CoV-2 Test

Read more
7 Jan 2021 13:51

IN BRIEF: Avacta Group Enters License Agreement With Point Biopharma

IN BRIEF: Avacta Group Enters License Agreement With Point Biopharma

Read more
7 Jan 2021 08:58

Avacta enters licence agreement with Point Biopharma

(Sharecast News) - Cancer therapy and diagnostics developer Avacta Group has entered into a licence agreement with Point Biopharma, it announced on Thursday, to provide access to its 'preCISION' technology for the development of tumour-activated radiopharmaceuticals.

Read more
23 Dec 2020 19:50

UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost

UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost

Read more
23 Dec 2020 08:56

Avacta submits clinical trial application for 'AVA6000' prodrug

(Sharecast News) - Cancer therapy developer Avacta Group has submitted a clinical trial application in the UK for a phase 1 first-in-human open label dose-escalation and expansion study of its lead 'preCISION' prodrug, 'AVA6000', in patients with locally-advanced or metastatic selected solid tumours, it announced on Wednesday.

Read more
21 Dec 2020 18:10

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

Read more
21 Dec 2020 09:49

Avacta enters 'Affimer' licensing deal with Astrea Bioseparations

(Sharecast News) - Cancer therapies and diagnostics developer Avacta Group has entered into a licensing agreement with Astrea Bioseparations, it announced on Monday, for the use of the 'Affimer' platform in affinity purification applications.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.